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Summary
Background: During cytokinesis, regulatory signals are
presumed to emanate from the mitotic spindle. However,
what these signals are and how they lead to the spatiotem-
poral changes in the cortex structure, mechanics, and regional
contractility are not well understood in any system.
Results: To investigate pathways that link the microtubule
network to the cortical changes that promote cytokinesis, we
used chemical genetics in Dictyostelium to identify genetic
suppressors of nocodazole, a microtubule depolymerizer.
We identified 14-3-3 and found that it is enriched in the cortex,
helps maintain steady-state microtubule length, contributes to
normal cortical tension, modulates actin wave formation, and
controls the symmetry and kinetics of cleavage furrow
contractility during cytokinesis. Furthermore, 14-3-3 acts
downstream of a Rac small GTPase (RacE), associates with
myosin II heavy chain, and is needed to promote myosin II
bipolar thick filament remodeling.
Conclusions: 14-3-3 connectsmicrotubules, Rac, andmyosin
II to control several aspects of cortical dynamics, mechanics,
and cytokinesis cell shape change. Furthermore, 14-3-3 inter-
acts directly with myosin II heavy chain to promote bipolar
thick filament remodeling and distribution. Overall, 14-3-3
appears to integrate several critical cytoskeletal elements
that drive two important processes—cytokinesis cell shape
change and cell mechanics.
Introduction
Cytokinesis is driven by regional mechanical activities—
myosin II-based contractility, actin polymer dynamics, and
actin crosslinking. Over the years, we have discovered and
have been studying a two-component system of equatorial
and global/polar actin-associated proteins that govern these*Correspondence: dnr@jhmi.edudynamical and mechanical features of the dividing cell cortex.
The global pathway is controlled by aRac-family small GTPase
(encoded by the RacE gene), which regulates the distribution
of cortical actin crosslinkers and provides resistive stresses
to modulate furrow ingression kinetics [1–3]. Although active
cell shape change is ultimately driven and controlled by these
cortical mechanical features, the process is regulated spatially
and temporally by the mitotic spindle.
The mitotic spindle has two major structures—the central
spindle and the astral microtubule network—that regulate
the cortex (e.g., [4–6]); however, the molecular bases of these
signaling cascades are not well defined. The central spindle
signals are mediated partly by kinesin-6-family motors com-
plexed with two general sets of proteins, including MgcRac-
Gap (in metazoans) or the chromosomal passenger proteins
INCENP and Aurora kinase (in Dictyostelium protozoans and
metazoans) [7–10]. The astral microtubules play an important
role in many cell types, including Dictyostelium, echinoderms,
and C. elegans embryos where they help direct symmetry
breaking [4, 11, 12]. The major signaling pathway activated
by these astral microtubules has remained largely elusive,
though a heterotrimeric G protein pathway has been impli-
cated in some systems (e.g., [13]). Yet, Dictyostelium Gb null
mutants (Dictyostelium Gb is encoded by a single gene) are
primarily defective in chemotaxis-assisted scission [14]. Over-
all, significant gaps remain in our understanding of how the
mitotic spindle regulates the regional mechanics that drive
cytokinesis cell shape change.
Here, we used nocodazole to disturb microtubules and
searched for genes involved in microtubule-related regulatory
pathways via cDNA library suppression analysis. Using this
chemical-genetic approach, we identified 14-3-3 overexpres-
sion as a genetic suppressor of nocodazole. The 14-3-3
proteins are a family of abundant proteins that are widely ex-
pressed in all eukaryotic cells and are highly conserved from
Dictyostelium to mammals. 14-3-3 has been implicated in
cytokinesis completion, and the mammalian isoform 14-3-3s
is involved in mitotic translational control [15, 16]. Two iso-
forms are found in yeast, Drosophila, and C. elegans. Dictyos-
telium cells have only one isoform, whichmakes Dictyostelium
a unique system for 14-3-3 studies. Here, we present evidence
that 14-3-3 functions in a pathway linking microtubules, RacE,
and myosin II to cortex mechanics, cortical actin wave
dynamics, and cytokinesis shape control.
Results
14-3-3 Is a Genetic Suppressor of Nocodazole
To begin dissecting how the mitotic spindle modulates cytoki-
nesis, we challenged pools of cDNA library transformed cells
with nocodazole at IC50, the concentration that reduced the
growth rate by 50% (measured to be 10 mM). From 100 pools
of 1,000 cDNA library transformants (100,000 total transform-
ants), we recovered 14-3-3 (see sequence analysis in
Figure S1 available online) and a dominant-negative version
of enlazin (enl-tr), the Dictyostelium ezrin-radixin-moesin
(ERM)-family protein [17]. Both 14-3-3 and enl-tr recapitulated
the nocodazole suppression (Figure 1A), verifying the genetic
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Figure 1. Overexpression of 14-3-3 Rescues Nocodazole Inhibition, and Downregulation of 14-3-3 Introduces a Cytokinesis Defect
(A) Expression of 14-3-3OE, a dominant-negative version of enlazin (enl-tr), or 14-3-3-GFP recapitulates rescue of nocodazole inhibition (two-tailed
Student’s t test [ST]: p < 0.05, n R 5 for each condition). Control cells carried the empty vector. Cells were challenged with 10 mM nocodazole (IC50) or
dimethyl sulfoxide (DMSO).
(B) Western analysis showing the expression levels of 14-3-3 in wild-type (WT), WT:14-3-3hp, WT:14-3-3OE, andWT:14-3-3-GFP cells. Dynacortin provides
a loading control.
(C) Quantification of 14-3-3 protein amounts in WT control (100%), WT:14-3-3hp (37%), WT:14-3-3-GFP (240%), andWT:14-3-3OE (210%) cells (n = 4). Inset
shows real-time reverse transcriptase-polymerase chain reaction result of knockdown of 14-3-3 mRNA in 14-3-3hp cells (level was 27% of control; n = 4).
(D) Quantitative western analysis showing absolute 14-3-3 protein amount inWT cells. Dilution series of total cell lysate and purified 14-3-3-His protein were
compared.
(E) Differential interference contrast (DIC) time series of aWT control cell (top) and aWT:14-3-3hp cell (bottom) undergoing cytokinesis. Scale bar represents
10 mm.
(F) Time 0 in (E) was defined as the point when the furrow diameter reachedDx (Dx is the point when the furrow diameter (FD) equaled the furrow length (FL) as
shown here).
(G) Rescaled furrow-thinning trajectories for WT control (Dx = 2.8 6 0.08; n = 14) and WT:14-3-3hp (Dx = 2.6 6 0.09; n = 15) cells.
(H) Graph showing the distribution of two daughter cells’ 2D-projected area ratio (larger area/smaller area). WT control cells are distributed from 1.0 to 1.2
(n = 20), whereas WT:14-3-3hp cells are distributed from 1.0 to 2.8 (1.8–2.8 are grouped in the histogram) (n = 31). These distributions are significantly
different (Mann-Whitney nonparametric test [MW]: p = 0.004).
Error bars represent standard error of the mean (SEM).
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1882interactions with nocodazole. Because enl-tr was originally
identified as a genetic suppressor of cortexillin-I mutants
[17], the recovery of 14-3-3 and enl-tr in this genetic selection
led us to ask whether 14-3-3 links the microtubule network to
the actin cortex to modulate cytokinesis contractility.
To initiate characterization of 14-3-3, we purified a recombi-
nant His-tagged 14-3-3 and generated polyclonal antibodies.
In the 14-3-3 overexpression cell-lines, 14-3-3 levels were
increased approximately 2-fold relative to control cells
(Figures 1B and 1C). We also quantified the wild-type (WT)cellular concentration of 14-3-3, which was 1.4 mM monomer,
corresponding to a 0.7 mM dimer (the typical functional unit
of 14-3-3) concentration (Figure 1D). This concentration is
similar to that found for other actin-associated proteins,
including dynacortin (1 mM) [18], fimbrin (0.6 mM) [19], and
myosin II (3.4 mM) [20].
Downregulation of 14-3-3 Induces Cytokinesis Defects
We attempted to delete 14-3-3 by homologous recombination.
However, this effort yielded highly enlarged, fragile cells
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1883(typical of multinucleated cells with a severe cortical defect),
which diedwithin a few generations (Figures S2A–S2C). There-
fore, we downregulated 14-3-3 expression levels by using
a hairpin construct (14-3-3hp). Our data confirmed that 14-3-
3 is an essential gene: complete silencing by the hairpin simi-
larly killed the cells under standard drug conditions. However,
we established a protocol for achieving partial RNA interfer-
ence (RNAi), allowing the recovery of WT:14-3-3hp cells (WT
cells expressing the 14-3-3hp plasmid) with a 60%–70%
knockdown of both RNA and protein levels (Figures 1B and
1C). These cells had a slower growth rate in suspension culture
(Figure S2D) and a larger overall cell size (Figure S2E) as
compared with control cells. DAPI staining revealed that these
enlarged 14-3-3hpcellsweremultinucleated, indicating a cyto-
kinesis defect (Figures S2E and S2F). The 14-3-3 levels were
inversely correlated with the degree of multinucleation
(severity of the cytokinesis defect) (Figure S2G).
To assess how 14-3-3 contributes to cytokinesis contrac-
tility, we quantified the furrow ingression dynamics using our
rescaling scheme [2, 3, 17]. In this scheme, wild-type cleavage
furrows ingress following a slow, nonlinear trajectory. In con-
trast, mutants in either the global or equatorial pathways divide
following a multiphasic trajectory in which the early stage is
slow and the late phase accelerates relative to the initial phase.
As compared to wild-type cells, WT:14-3-3hp cells have an
altered furrowmorphology (Figure 1E) andamultiphasic furrow
ingression dynamic (Figures 1F and 1G). The differential inter-
ference contrast time-lapse and the rescaled furrow-thinning
dynamics show that downregulation of 14-3-3 slows down
the initial bridge ingression. Finally, these 14-3-3hp cells also
exhibit an elongated bridge length and have a higher proba-
bility of asymmetrical division as reflected by the area ratio of
the two daughter cells (Figures 1E and 1H). To summarize,
14-3-3 ensures symmetrical cell division and wild-type furrow
ingression dynamics. It is worth noting that the morphology
and dynamics of the 14-3-3hp cytokinesis are highly reminis-
cent ofmyoII null cytokinesis [2, 3].
14-3-3 Enriches at the Cell Cortex
Next, we analyzed the subcellular localization of 14-3-3 by
immunocytochemistry and by live-cell imaging of cells
expressing 14-3-3-GFP. By immunocytochemistry, 14-3-3
was found to be concentrated in the cortex of wild-type and
14-3-3-overexpressing (14-3-3OE) cells but was depleted
from the cortex in 14-3-3hp cells (Figure 2A). Similarly, 14-3-
3-GFP showed cortical enrichment that was distinct from
soluble GFP in live cells (Figure S2H). Mutation (K49E; [21]) of
the key conserved lysine in 14-3-3’s ligand-binding cleft
partially reduced the cortical enrichment of 14-3-3, indicating
that the cortical enrichment is dependent on ligand binding
(Figure S2H). During cytokinesis, 14-3-3 was enriched in the
global/polar cortex in fixed (Figure 2B) and live (Figure S2I)
cells. We did not observe clear colocalization of 14-3-3 with
microtubules by either method. To ensure that the 14-3-3-
GFPwas functional, we confirmed its ability to rescue nocoda-
zole treatment, which was similar to that of the untagged
version (Figure 1A).
14-3-3 Maintains Steady-State Microtubule Lengths
Because 14-3-3 was recovered as a genetic suppressor of no-
codazole, we examined the microtubule structures in control
cells and in cells with altered 14-3-3 expression levels with or
without nocodazole (Figure 2C). To simplify the analysis, we
examined the total microtubule length by epifluorescencemicroscopy when cells were flattened with a sheet of agarose
(Figure 2C).We found that the averagemicrotubule wasw30%
shorter in 14-3-3hp cells, whereas 14-3-3OE did not signifi-
cantly alter the average microtubule length. Upon nocodazole
treatment, the average length decreased fromw10 mm to 2 mm
in control cells, whereas 14-3-3OE cells had longer microtu-
bules than the control cells had.
Because 14-3-3 was enriched in the cortex, we sought to
determine whether alteration of 14-3-3 levels specifically
changed the extent and dynamics of microtubule-cortex inter-
actions. Here, we define the microtubule-cortex interaction
site as the region of the microtubule detected by total internal
reflection fluorescence microscopy, which only illuminates
w200 nm from the cell-surface interface (Figure S3A).
We developed a semiautomated microtubule-tracking algo-
rithm to quantify the microtubule-cortex interaction length
and lifetime. We found that the lifetimes of the microtubule-
cortex interactions were similar (t z 5 s) for all genotypes
(WT control, WT:14-3-3OE, and WT:14-3-3hp) with or without
nocodazole (data not shown). We also analyzed the microtu-
bule-cortex contact length distributions (Figure S3B).
We found that without nocodazole, perturbation of 14-3-3
levels significantly altered these distributions, whereas with
nocodazole, the data interpretation was complicated by the
fact that nocodazole-treated cells were more photosensitive.
Because 14-3-3hp cells had a cytokinesis defect (Figure 1)
and an interphase microtubule structural defect (Figure 2C),
we needed to determine whether there was a defect in mitotic
spindle-associated microtubules. However, it is difficult to
detect all astral microtubules making contact with the cortex.
Instead, we analyzed the mitotic spindle dynamics, specifi-
cally the spindle length change and angular velocity. We could
not find any quantitative impact on the mitotic spindle
dynamics upon 14-3-3 depletion (Figure S3C).
The cortical localization of 14-3-3 led us to test whether it is
involved in cortical mechanics. Wemeasured effective cortical
tension via micropipette aspiration. When wild-type cells were
treated with nocodazole (10 mM), the cortical tension was
reduced by 60% (Figure 2D). Overexpression of 14-3-3
partially rescued the cortical tension defect of nocodazole-
treated cells (raising it from 0.4 to 0.8 nN/mm; Figure 2D).
In contrast, 14-3-3hp cells had a 40% reduction in interphase
cortical tension (Figure 2E), and expression of the ligand-
binding mutant 14-3-3(K49E) had a dominant-negative effect
on cortical tension, reducing it by 30% compared to WT
control (Figure 2F). These observations suggest that 14-3-3
works with microtubules to control cortical mechanics.
14-3-3 Functions Downstream of RacE to Regulate the Cell
Cortex and Cytokinesis
RacE is important for cytokinesis, cortical tension, and the
cortical accumulation of the global actin crosslinkers dynacor-
tin and coronin [1, 22]. Though dynacortin and coronin are
downstream of RacE, the pathways governed by RacE are
largely unknown. Because 14-3-3 also controls cortical
tension and is globally distributed during cytokinesis, we
tested whether 14-3-3 participates in the RacE signaling
pathway. 14-3-3-GFP was expressed in RacE null cells, and
the localization of 14-3-3-GFP was examined. Without RacE,
14-3-3-GFP failed to accumulate in the cortex (Figure 3A).
However, when the cells were complemented with mCherry-
RacE, the cortical localization of 14-3-3 was restored
(Figure 3A). To begin to characterize this RacE dependency
of 14-3-3’s cortical localization, we tested 14-3-3’s solubility.
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Figure 2. Cortically Enriched 14-3-3 Contributes to Cortical Mechanics and Microtubule Length
(A) Anti-14-3-3 immunocytochemistry of WT control, WT:14-3-3hp, and WT:14-3-3OE cells shows that 14-3-3 is enriched in the cortex. Line scan shows the
two peaks of 14-3-3 signal on the cell edges. Cartoon shows the method of quantifying the ratio of intensities of the cortex to cytoplasm. Histogram shows
the relative intensity (Icort) and the cortex/cytoplasm intensity ratios (Icort/Icyto) from fixed-cell imaging (n = 10 cells for each strain). For both parameters,
14-3-3 levels of 14-3-3hp and 14-3-3OE are significantly different from control (ST: p < 0.001). Error bars represent SEM.
(B) Two examples of fixed dividing wild-type cells stainedwith DAPI and anti-14-3-3 antibody, showing that 14-3-3 is enriched at the cortex but diminished in
the cleavage furrow cortex.
(C) Whole microtubules were visualized by epifluorescence after the cells were flattened by a slice of agarose. GFP-tubulin-labeled WT control, WT:14-3-
3OE, and WT:14-3-3hp cells were treated with DMSO or 10 mM nocodazole for 30 min before imaging. Graph shows the total microtubule length of WT
control, WT:14-3-3OE, andWT:14-3-3hp cells without (DMSO) or with nocodazole treatment. Total microtubule length is much shorter in WT:14-3-3hp cells
compared toWT control cells (ST: p < 0.0001). Nocodazole treatment significantly shortened the total length ofmicrotubules in all three strains, but 14-3-3OE
cells had a significantly longer total microtubule length in nocodazole (ST: p < 0.0001).
(D–F) Quantification of effective cortical tension measurements by micropipette aspiration.
(D) Nocodazole treatment (5 mM for 30 min) significantly reduced the effective cortical tension of wild-type cells from 1.0 to 0.42 nN/mm (ST: p < 0.0001), and
overexpression of 14-3-3 partially rescued the cortical tension to 0.78 nN/mm (ST: p < 0.001).
(E) The effective cortical tension was significantly reduced in WT:14-3-3hp cells from 1.1 to 0.63 nN/mm (ST: p < 0.0001). 14-3-3OE raised RacE mutant
cortical tension from 0.31 to 0.54 nN/mm (ST: p < 0.001). 14-3-3OE did not affect the cortical tension of myoII null cells.
(F) Expression of 14-3-3(K49E)-GFP reduced cortical tension by 30% as compared to WT control cells (ST: p = 0.009).
Values plotted in (C)–(F) are mean 6 SEM, with sample sizes listed on the bars.
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1884We lysed cells with 0.1% NP-40 and found that a greater frac-
tion (w30% versus less than w10%) of 14-3-3 sedimented in
the pellet fraction when RacE was expressed in the cell and
GTP was provided in the lysis buffer (Figure 3B). Stronger
detergents such as 0.1% Triton X-100 disrupted this GTP-
and RacE-dependent fraction, suggesting that the insoluble
fraction has a membrane component rather than being purelycytoskeleton associated. Furthermore, overexpression of
14-3-3 partially rescued the cortical tension defect in RacE
null cells (Figure 2E). RacE null cells have a cortical tension
that is 30% of wild-type, but when 14-3-3 is overexpressed,
the cortical tension was nearly doubled to 55% of wild-
type. Together, these findings suggest that 14-3-3 participates
in the signaling pathway from RacE to the cortical
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Figure 3. 14-3-3 Depends on RacE for Cortical
Localization, and 14-3-3OE Partially Rescues
RacE Cytokinesis
(A) 3D deconvolution of RacE null (left) or
mCherry-RacE-rescued RacE (right) cells ex-
pressing 14-3-3-GFP. Line scans show the
cortical 14-3-3 levels. The histogram at right
shows quantification of cortical 14-3-3 relative
to the cytoplasm in RacE null and rescued RacE
cells. The samples are significantly different
from each other (ST: p < 0.0001).
(B) Increased separation of 14-3-3 into the insol-
uble (pellet) fraction (P) from RacE:GFP-RacE
lysates supplemented with GTP. Addition of
GDP or preparation of lysates fromRacE null cells
caused 90% of the 14-3-3 to fractionate in the
supernatant fraction (S). Equivalent volumes
were loaded in each lane. The histogram at
bottom shows the quantification of the fraction
of 14-3-3 pelleted (n = 3 for each condition); the
amount of 14-3-3 found in the pellet fraction in
the RacE:GFP-RacE + GTP sample was signifi-
cantly greater than the other samples (ST:
p < 0.05 for each comparison).
(C) DIC time series showing dividing RacE:14-3-
3OE and RacE cells. Time 0 is the time point
when the relative diameter (rescaled by Dx)
equals 1.
(D) Rescaled furrow-thinning trajectories of
RacE:14-3-3OE (n = 8), RacE control (n = 20),
and WT (n = 14) cells show that RacE:14-3-3OE
furrow ingression dynamics are more similar to
WT cells than RacE control cells.
(E) Relative growth rates of RacE:GFP-RacE,
RacE:14-3-3OE, and RacE cells. Both
RacE:GFP-RacE andRacE:14-3-3OE grow signif-
icantly more quickly than RacE control (ST:
p < 0.01 in both cases).
(F) Relative growth rates of cortexillin-I (cortI),
cortI:Enl-tr, and cortI:14-3-3OE cells. 14-3-3
was unable to rescue cortI cells, whereas Enl-tr
partially rescued cortI mutants (ST: p < 0.001).
Error bars represent SEM, with sample sizes
listed on the bars in (A), (E), and (F).
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1885cytoskeleton: 14-3-3 depends on RacE for its cortical localiza-
tion and its separation into the NP40-insoluble fraction, and
overexpression of 14-3-3 partially rescues the mechanical
defect in RacE null cells.
Because RacE and 14-3-3mutants have severe mechanical
defects, we examined the actin network of these cells. Here,
we expressed GFP-tagged LimEDcoil to identify polymeric
actin in wild-type or WT:14-3-3hp cells and discovered that
14-3-3 modulates cortical actin wave formation (Figures
S3D–S3H; Table S2). Actin waves are dynamic actin assem-
blies that form at the cell-substrate interface and propagate
along the surface in a manner dependent on Arp2/3 and
myosin I, but not myosin II [23]. 14-3-3-GFP itself did not
show wave behavior (data not shown). RacE mutants also
showed a suppressed cortical actin activity in the same assay,
though the qualitative features were slightly different in this
strain background (data not shown). In combination, these
observations indicate that 14-3-3 modulates cortex
mechanics downstream of RacE, whichmay then have an indi-
rect effect on cortical actin wave dynamics.
We next tested whether 14-3-3 could rescue the RacE null
cytokinesis and suspension growth defects. As compared toRacE null cells, the cytokinesis morphology was qualitatively
rescued (Figure 3C) and the furrow ingression dynamics
were quantitatively slowed down in RacE:14-3-3OE cells,
making them more wild-type-like (Figure 3D). Furthermore,
14-3-3 overexpression partially rescued the suspension
growth defect of RacE null cells (Figure 3E). This genetic
suppression is specific to RacE null cells, because it failed to
suppress cortI null (Figure 3F), myoII null, and kif12 null cells
(kif12 encodes the Dictyostelium kinesin-6-family protein
[24]), all of which are cell lines with severe cytokinesis defects
in suspension culture (data not shown). Thus, 14-3-3 specifi-
cally acts in a pathway that links the microtubule network
and RacE and controls cell mechanics and cytokinesis shape
progression.
14-3-3 Associates with Myosin II, Regulating
Its Distribution and Assembly
To determine how 14-3-3 controls cytokinesis and cortical
mechanics, we used high-resolution mass spectrometry
to identify novel 14-3-3 binding partners. We expressed
a 14-3-3-FLAG protein in cells and isolated associated
proteins by anti-FLAG coimmunoprecipitation (Figure S4A).
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searching and prioritized via a spectral counting-based
protein quantification and statistical analysis strategy (see
Supplemental Experimental Procedures). From this, a list of
potential 14-3-3 interactors was assembled (Figure S4B). As
expected, the most abundant protein identified from the anti-
FLAG immunoprecipitation was 14-3-3. The third most abun-
dant protein was myosin II heavy chain protein, and other
proteins of interest included fimbrin and myosin II heavy chain
kinase. Given the roles of 14-3-3 and myosin II in cortical
mechanics and cytokinesis, we chose to focus on their interac-
tions first. Using antibodies directed against myosin II heavy
chain and 14-3-3, we tested whether endogenous myosin II
and 14-3-3 do in fact associate (Figures 4A and 4B). These
endogenous proteins could be reciprocally coimmunoprecipi-
tated (in case the proteins associated indirectly through actin,
Mg2+ and ATPwere included in the buffers to prevent myosin II
from locking onto actin). Using sequence analysis, we found
several motif 2 and 3, but nomotif 1, consensus 14-3-3 binding
sites in themyosin II heavy chain peptide (Figure S4C). Three of
these binding sites overlapped or were adjacent to three crit-
ical threonines in the myosin II heavy chain tail that regulate
myosin II bipolar thick filament (BTF) assembly [25]. The BTF
assembly-incompetent phosphomimic myosin II 33Asp
(where the three threonines have been substituted with as-
partic acids) failed to coimmunoprecipitate 14-3-3. Therefore,
14-3-3 likely only associates with assembly-competent
myosin II.
To determine whether this association is functionally rele-
vant, we examined the distribution of GFP-myosin II
(expressed in a myoII null background) and found that GFP-
myosin II distribution was severely altered in 14-3-3hp cells
(Figure 4C). In particular, myosin II was significantly less
uniform, even punctate, in 14-3-3hp cells. During cytokinesis,
GFP-myosin II could still accumulate at the furrow but did so
in a highly aggregated fashion (Figure 4C). In contrast, 14-3-3
overexpression did not appear to alter the wild-type GFP-
myosin II distribution (Figure 4C). Finally, 14-3-3 required
myosin II in order to accumulate in the cortex (data not shown).
To determine how 14-3-3 impacts BTF assembly dynamics,
we performed fluorescence recovery after photobleaching
(FRAP) analysis of GFP-myosin II in the cleavage furrow and
interphase cortices (Figure 4D; Figure S4D). For all genotypes
(WT control, WT:14-3-3OE, and WT:14-3-3hp), GFP-myosin II
had a recovery time (trec) of 3–5 s in interphase and cleavage
furrow cortices. However, the immobile fraction was signifi-
cantly increased in the 14-3-3hp cells in both the cleavage
furrow and the interphase cortex (Figure 4D; Figure S4D). Over-
all, we found a general trend in which the immobile fractions
increased such that 14-3-3OE < control < 14-3-3hp. These
observations indicate that 14-3-3 associates with assembly-
competent myosin II, increasing its mobility so that it can
remodel along the interphase and cleavage furrow cortices.
To test whether 14-3-3 directly impacts myosin II assembly,
we performed BTF assembly assays with purified myosin II
from Dictyostelium and recombinant Dictyostelium 14-3-3-
His purified from E. coli. BTF assembly is highly salt depen-
dent, with the optimal concentrations for myosin II BTF
assembly occurring in the range of 25 to 100 mM NaCl [25].
Using equimolar (250 nM) 14-3-3 dimer and myosin II hexame-
ric monomer (two heavy chains, two regulatory light chains,
and two essential light chains), we measured the percentage
of soluble myosin II as a function of salt concentration
(Figure 4E). Under these conditions, 20% of the myosin IIremains soluble due to the critical concentration of myosin II
in the range of 25–100mMsalt.We found that 14-3-3 increased
the fraction of soluble myosin slightly from w20% to w30%.
This level of soluble myosin II is similar to that measured for
the 13Asp and 23Asp mutant myosins, rather than the full
33Asp assembly-incompetent myosin II [26]. We could not
detect appreciable increases in the 14-3-3 levels in the
insoluble assembled fraction,most likely because 14-3-3 inter-
acts in a highly substoichiometric manner with the myosin II
monomers in the BTFs. Synthesizing the in vivo FRAP and
in vitro BTF assembly results, 14-3-3 shifts myosin II out of
the assembled state in vitro and increases the mobile fraction
in vivo in order to allow the myosin II to remodel and redis-
tribute around the cell cortex. Because 14-3-3 promotes
myosin II mobility and both proteins contribute to cortical
mechanics, we asked whether 14-3-3 required myosin II in
order to have an impact on cortical tension. We found that
14-3-3OE did not have an effect on the cortical tension ofmyoII
null cells (Figure 2E). Thus, 14-3-3 works through myosin II to
control cortical tension.
Discussion
Cytokinesis shape change occurs over a fast, five-minute time
span, requiring considerable cortical remodeling during this
time frame. Much insight has come from studying the myosin
heavy chain kinases (MHCK), which phosphorylate the critical
threonines in the tail of myosin II heavy chain to control BTF
assembly [25, 27]. Most likely, the role of these enzymes is to
set the level of the free pool of myosin II monomers (w80%)
in the cell. This free pool is then maintained through flux of
the assembled and disassembled BTF states and is required
to ensure that the contractile network is turned over during
processes like motility and cytokinesis. 14-3-3 also impacts
this dynamic, preventing the myosin II from forming higher-
order assemblies and shifting the assembly equilibrium.
Importantly, the cellular concentrations of myosin II in the
BTF state and the 14-3-3 dimer are identical (0.7 mM), indi-
cating that hypotheses of direct biochemical modulation of
BTF assembly by 14-3-3 are reasonable. Four scenarios may
be envisioned for how 14-3-3 might modulate BTF dynamics.
First, by binding to unphosphorylated monomers, 14-3-3
may suppress myosin II thick filament nucleation and/or
elongation so that fewer well-structured BTFs are assembled.
Second, 14-3-3 may bind transiently to the mature BTF,
lowering individual monomer affinity and helping it to release
from the BTF. Third, the in vivo system may be more complex
where 14-3-3 binds to the BTF, putting the myosin monomers
in a configuration that makes them more ideal substrates for
MHCK. Considering that MHCK was identified as a potential
14-3-3 protein interactor in our mass spectrometric analysis,
such a tertiary complex of myosin BTF-MHCK-14-3-3 might be
formed. Fourth, 14-3-3 might form part of the myosin II BTF
cortical receptor/anchoring complex. In no system is it well
established how myosin II BTFs are anchored to the cortex.
In dividing 14-3-3hp cells, the myosin II aggregates appear
to dislodge from the cortex, suggesting that 14-3-3 might
contribute to cortical anchoring. Overall, this system is
highly dynamic, with all of the measured timescales occurring
on the order of low seconds. The data also demonstrate
that if myosin II BTFs are not distributed uniformly, they
cannot contribute to cortex mechanics, and therefore the
14-3-3hp cortical tension and cytokinesis morphology closely
resembles that of myoII null cells. These observations may
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Figure 4. 14-3-3 Associates with Myosin II, Facilitating Myosin II Cortical Remodeling
(A) 14-3-3 coimmunoprecipitates with endogenous WT myosin II, but not with 33Asp myosin II (bottom panel). Preimmune sera are shown for additional
controls. Total input of endogenous and 33Asp myosin II and 14-3-3 is shown in the top panels. Bead IP refers to the antibody used for the immunopre-
cipitation; IB refers to the antibody used for the immunoblots. For (A) and (B), Mg2+ and ATP were added to the lysis buffers to ensure that the association
did not occur through myosin-actin interactions.
(B) Endogenous myosin II coimmunoprecipitates with endogenous 14-3-3.
(C) GFP-myosin II is more punctate in 14-3-3hp cells, whereas 14-3-3OE does not affect the distribution of GFP-myosin II. During cytokinesis, GFP-myosin II
can still localize in the cleavage furrow cortex but is highly punctate. Scale bars represent 10 mmand apply to all panels in each group. Histogram shows the
percentage of cells with uniform (nonpunctate) GFP-myosin II. The 14-3-3hp cells had a significantly lower fraction of cells with uniformmyosin II distribution
(comparison of proportions: z = 15.6; p < 63 1026). Error bars represent SEM, with sample sizes listed on the bars. For (C) and (D), ‘‘WT’’ cells aremyoII null
cells rescued with wild-type GFP-myoII. Control cells carry the empty vector.
(D) As observed from FRAP analysis, 14-3-3hp increases the immobile fraction of GFP-myosin II at the cleavage furrow. Numbers at upper left of each frame
are time in seconds. Time 0 is the first frame after photobleaching. The frame below is one t time unit (e-fold time) after photobleaching measured for the
presented cell. Frequency histograms show the distributions of immobile fractions (means6SEMand sample sizes are listed).WT control and 14-3-3OE are
indistinguishable. The myosin II immobile fraction for WT:14-3-3hp is significantly higher (ST: p < 0.001*) than that found in WT and WT:14-3-3OE cell lines.
(E) 14-3-3 protein shifts the myosin II bipolar thick filament assembly equilibrium in vitro. Purified myosin II showsw20% soluble (unassembled) myosin II in
the salt range of 25–100mMNaCl. With the addition of equimolar 14-3-3 (250 nMdimer) at 25 and 50mMNaCl, moremyosin II remains soluble (ST: p < 0.05*).
The mean 6 SEM (n = 6–7) is provided for each salt concentration.
(F) Cartoonmodel showing the pathway elucidated in the text whereby 14-3-3 connectsmicrotubules andRac tomyosin II to control cortical mechanics, cell
shape, and cytokinesis.
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1887prove to be generalizable to other systems, because mamma-
lian myosin II appeared on the list of potential 14-3-3s interac-
tors in a proteomics study [16]. Furthermore, 14-3-3 may
contribute to myosin II activation in many ways, because ithas also been implicated in regulatingmammalianmyosin light
chain phosphatase [28].
14-3-3 also functions downstream of RacE: its cortical
localization depends on RacE; its solubility depends on
Current Biology Vol 20 No 21
1888RacE and GTP; and its overexpression in RacE null cells
partially rescues the growth, cortical tension, and cytokinesis
defects. Though we were unable at this time to demonstrate
direct binding between 14-3-3 and RacE, these data demon-
strate that 14-3-3 links at least indirectly to RacE. These
data also suggest that the cortical localization of 14-3-3
reflects where active RacE is found. RacE is uniformly distrib-
uted around the plasma membrane during cell division [29]
and may regulate one or more of the global/polar-module
proteins [1]. Significantly, 14-3-3 enriches all along the cell
cortex but is reduced in the cleavage furrow region. Because
myosin II was still able to accumulate in the cleavage furrow
cortex in the 14-3-3hp cells, active RacE may promote 14-3-
3 accumulation in the polar cortex where it helps remodel
the myosin II BTFs.
14-3-3 may also modify the function of several other cortical
actin-associated proteins such as dynacortin, fimbrin, coro-
nin, enlazin, and LimE [30]. Several of these proteins contain
predicted consensus 14-3-3 binding motifs and are found in
concentrations comparable to 14-3-3. Fimbrin appeared on
the list of potential interactors (Figure S4B); however, we
have been unable thus far to recapitulate the fimbrin-14-3-3
interaction via standard coimmunoprecipitation assays. This
is possibly due to fimbrin’s short cortical association time
(260 ms) [3]. Interestingly, 14-3-3 proteins often bind to phos-
phorylated ligands, and a number of phosphorylated proteins
reside in the cortex (e.g., dynacortin is a phosphoprotein [1]).
Similarly, sea urchin embryos accumulate multiple cortical
phosphoproteins during cell division, and this accumulation
is inhibited by nocodazole treatment [31].
Finally, microtubules contribute to cortical mechanics,
probably through a signaling pathway that includes 14-3-3.
In return, 14-3-3 contributes to the steady-state microtubule
structures and modulates cortical mechanics through RacE
and myosin II (Figure 4F). Therefore, this is not a linear
pathway but what appears to be a circular (feedback)
system between the microtubules and the cortex. The
combination of these observations then leads to the ques-
tion of whether the manner in which the spindle regulates
the cortex is really through a feedback system where the
spindle directs the cortex and the cortex directs the spindle
[32]. In this case, cytokinesis symmetry breaking may occur
through bidirectional communication between these two
structures. Similar ideas have been suggested elsewhere
[33, 34]. Overall, 14-3-3 coordinates three major cytoskeletal
elements—microtubules, actin, and myosin II—to control
two critical processes, cytokinesis fidelity and cortical
mechanics.Experimental Procedures
Experimental procedures for Dictyostelium strains, cell culture and
plasmids, cDNA library screening, cell growth in suspension and growth
rate determination, RNAi analysis, DAPI staining and nuclei/cell ratio
determination, antibody production and western analysis, immunocyto-
chemistry, cytokinesis analysis, microtubule analysis, actin wave
analysis, effective cortical tension measurements, anti-FLAG coimmuno-
precipitation, mass spectrometry analysis, 14-3-3-myosin II coimmuno-
precipitation, FRAP analysis, and in vitro BTF assembly can be found
in Supplemental Experimental Procedures. For statistical analysis, signif-
icance was determined by two-tailed Student’s t test, Mann-Whitney
nonparametric test, or comparing proportions (CP) where the standard
error is defined as SE = O(f(1 2 f)/n), where f is the fraction of cells
showing a behavior and n is the sample size. The p values are provided
for each test in the relevant figure legends; for CP, the z values are also
provided.Supplemental Information
Supplemental Information includes Supplemental Experimental Proce-
dures, four figures, and two tables and can be found with this article online
at doi:10.1016/j.cub.2010.09.048.
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